These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32883228)

  • 1. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
    Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
    BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
    Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
    Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.
    Lee JW; Lee JH; Park Y; Lee W; Kwon J; Song KB; Hwang DW; Kim SC
    Cancer Res Treat; 2020 Jul; 52(3):886-895. PubMed ID: 32164049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma.
    Ruzzenente A; Bagante F; Ardito F; Campagnaro T; Scoleri I; Conci S; Iacono C; Giuliante F; Guglielmi A
    Surgery; 2018 Aug; 164(2):244-250. PubMed ID: 29801730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.
    Zhang Y; Wu Z; Wang X; Li C; Chang J; Jiang W; Wang H; Wang Y; Li X
    BMC Cancer; 2020 Oct; 20(1):1044. PubMed ID: 33126868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma.
    Gaspersz MP; Buettner S; van Vugt JLA; de Jonge J; Polak WG; Doukas M; Ijzermans JNM; Koerkamp BG; Willemssen FEJA
    J Gastrointest Surg; 2020 Jul; 24(7):1612-1618. PubMed ID: 30756314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suggestions for improving perihilar cholangiocarcinoma staging based on an evaluation of the seventh edition AJCC system.
    Kwon W; Jang JY; Chang YR; Jung W; Kang MJ; Kim SW
    J Gastrointest Surg; 2015 Apr; 19(4):666-74. PubMed ID: 25572971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
    Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
    World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Klatskin tumor: long-term survival following surgery].
    Juntermanns B; Fingas CD; Sotiropoulos GC; Jaradat D; Dechêne A; Reis H; Kasper S; Paul A; Kaiser GM
    Chirurg; 2016 Jun; 87(6):514-9. PubMed ID: 27090415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
    Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
    Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes.
    Conci S; Ruzzenente A; Sandri M; Bertuzzo F; Campagnaro T; Bagante F; Capelli P; D'Onofrio M; Piccino M; Dorna AE; Pedrazzani C; Iacono C; Guglielmi A
    Eur J Surg Oncol; 2017 Apr; 43(4):743-750. PubMed ID: 28094085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual biliary intraepithelial neoplasia without malignant transformation at resection margin for perihilar cholangiocarcinoma does not require expanded resection: a dual center retrospective study.
    Xu Z; Fan X; Zhang C; Li Y; Jiang D; Hu F; Pan B; Huang Y; Zhang L; Lau WY; Liu X; Chen Z
    World J Surg Oncol; 2024 Jun; 22(1):161. PubMed ID: 38907218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
    J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma.
    Buettner S; van Vugt JL; Gani F; Groot Koerkamp B; Margonis GA; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Guglielmi A; IJzermans JN; Pawlik TM
    J Gastrointest Surg; 2016 Oct; 20(10):1716-24. PubMed ID: 27412318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.